Azevedo A, Prado AF, Antonio RC, Issa JP, Gerlach RF (2014) Matrix metalloproteinases are involved in cardiovascular diseases. Basic Clin Pharmacol Toxicol 115(4):301–314. https://doi.org/10.1111/bcpt.12282
Article CAS PubMed Google Scholar
Bennett MR, Sinha S, Owens GK (2016) Vascular smooth muscle cells in atherosclerosis. Circ Res 118(4):692–702. https://doi.org/10.1161/circresaha.115.306361
Article CAS PubMed PubMed Central Google Scholar
Braga SF, Neves JR, Ferreira J, Carrilho C, Simões JC, Mesquita A (2019) Neointimal hyperplasia. Rev Port Cir Cardiotorac Vasc 26(3):213–217
Bruczko M, Gogiel T, Wolańska M, Kowalewski R, Sobolewski K, Romanowicz L (2019) MT1-MMP evaluation in neointimal hyperplasia in the late follow-up after prosthesis implantation. Int J Exp Pathol 100(2):94–101. https://doi.org/10.1111/iep.12310
Article CAS PubMed PubMed Central Google Scholar
Carrizzo A, Izzo C, Forte M, Sommella E, Di Pietro P, Venturini E, Ciccarelli M, Galasso G, Rubattu S, Campiglia P, Sciarretta S, Frati G, Vecchione C (2020) A novel promising frontier for human health: the beneficial effects of nutraceuticals in cardiovascular diseases. Int J Mol Sci. https://doi.org/10.3390/ijms21228706
Article PubMed PubMed Central Google Scholar
Chen R, McVey DG, Shen D, Huang X, Ye S (2023) Phenotypic switching of vascular smooth muscle cells in atherosclerosis. J Am Heart Assoc 12(20):e031121. https://doi.org/10.1161/jaha.123.031121
Article CAS PubMed PubMed Central Google Scholar
Chu T, Huang M, Zhao Z, Ling F, Cao J, Ge J (2020) Atorvastatin reduces accumulation of vascular smooth muscle cells to inhibit intimal hyperplasia via p38 MAPK pathway inhibition in a rat model of vein graft. Arq Bras Cardiol 115(4):630–636. https://doi.org/10.36660/abc.20190231. Atorvastatina Reduz o Acúmulo de Células Musculares Lisas Vasculares para Inibir a Hiperplasia Intimal pela Inibição de Via p38 MAPK em um Modelo de Enxerto de Veia em Ratos
Article CAS PubMed PubMed Central Google Scholar
Déglise S, Bechelli C, Allagnat F (2022) Vascular smooth muscle cells in intimal hyperplasia, an update. Front Physiol 13:1081881. https://doi.org/10.3389/fphys.2022.1081881
Forte A, Rinaldi B, Berrino L, Rossi F, Galderisi U, Cipollaro M (2014) Novel potential targets for prevention of arterial restenosis: insights from the pre-clinical research. Clin Sci Lond 127(11):615–634. https://doi.org/10.1042/cs20140131
Article CAS PubMed Google Scholar
Frismantiene A, Philippova M, Erne P, Resink TJ (2018) Smooth muscle cell-driven vascular diseases and molecular mechanisms of VSMC plasticity. Cell Signal 52:48–64. https://doi.org/10.1016/j.cellsig.2018.08.019
Article CAS PubMed Google Scholar
Gomez D, Owens GK (2012) Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc Res 95(2):156–164. https://doi.org/10.1093/cvr/cvs115
Article CAS PubMed PubMed Central Google Scholar
Gupta A, Singh AK, Kumar R, Ganguly R, Rana HK, Pandey PK, Sethi G, Bishayee A, Pandey AK (2019) Corilagin in cancer: A critical evaluation of anticancer activities and molecular mechanisms [Review]. Molecules 24(18) Article 3399. https://doi.org/10.3390/molecules24183399
Han J, Wu J, Silke J (2020) An overview of mammalian p38 mitogen-activated protein kinases, central regulators of cell stress and receptor signaling. F1000Res. https://doi.org/10.12688/f1000research.22092.1
Article PubMed PubMed Central Google Scholar
Han JH, Park HS, Lee DH, Jo JH, Heo KS, Myung CS (2021) Regulation of autophagy by controlling Erk1/2 and mTOR for platelet-derived growth factor-BB-mediated vascular smooth muscle cell phenotype shift. Life Sci 267:118978. https://doi.org/10.1016/j.lfs.2020.118978
Article CAS PubMed Google Scholar
He B, Chen D, Zhang X, Yang R, Yang Y, Chen P, Shen Z (2022) Antiatherosclerotic effects of corilagin via suppression of the LOX-1/MyD88/NF-κB signaling pathway in vivo and in vitro. J Nat Med 76(2):389–401. https://doi.org/10.1007/s11418-021-01594-y
Article CAS PubMed Google Scholar
Hu C, Zuo K, Li K, Gao Y, Chen M, Hu R, Liu Y, Chi H, Wang H, Qin Y, Liu X, Zhong J, Cai J, Yang X, Li J (2020) P38/JNK is required for the proliferation and phenotype changes of vascular smooth muscle cells induced by L3MBTL4 in essential hypertension. Int J Hypertens 2020:3123968. https://doi.org/10.1155/2020/3123968
Article CAS PubMed PubMed Central Google Scholar
Jain M, Singh A, Singh V, Maurya P, Barthwal MK (2016) Gingerol inhibits serum-induced vascular smooth muscle cell proliferation and injury-induced neointimal hyperplasia by suppressing p38 MAPK activation. J Cardiovasc Pharmacol Ther 21(2):187–200. https://doi.org/10.1177/1074248415598003
Article CAS PubMed Google Scholar
Li X, Deng Y, Zheng Z, Huang W, Chen L, Tong Q, Ming Y (2018) Corilagin, a promising medicinal herbal agent. Biomed Pharmacother 99:43–50. https://doi.org/10.1016/j.biopha.2018.01.030
Article CAS PubMed Google Scholar
Li Y, Yu Z, Zhao D, Han D (2021) Corilagin alleviates hypertrophic scars via inhibiting the transforming growth factor (TGF)-β/Smad signal pathway. Life Sci 277:119483. https://doi.org/10.1016/j.lfs.2021.119483
Article CAS PubMed Google Scholar
Liu FC, Liao CC, Lee HC, Chou AH, Yu HP (2022) Effects of corilagin on lipopolysaccharide-induced acute lung injury via regulation of NADPH oxidase 2 and ERK/NF-κB signaling pathways in a mouse model. Biology. https://doi.org/10.3390/biology11071058
Article PubMed PubMed Central Google Scholar
Lu QB, Wan MY, Wang PY, Zhang CX, Xu DY, Liao X, Sun HJ (2018) Chicoric acid prevents PDGF-BB-induced VSMC dedifferentiation, proliferation and migration by suppressing ROS/NFκB/mTOR/P70S6K signaling cascade. Redox Biol 14:656–668. https://doi.org/10.1016/j.redox.2017.11.012
Article CAS PubMed Google Scholar
Ma Z, Mao C, Jia Y, Fu Y, Kong W (2020) Extracellular matrix dynamics in vascular remodeling. Am J Physiol Cell Physiol 319(3):C481-C499. https://doi.org/10.1152/ajpcell.00147.2020
Article CAS PubMed PubMed Central Google Scholar
Ma SQ, Guo Z, Liu FY, Hasan SG, Yang D, Tang N, An P, Wang MY, Wu HM, Yang Z, Fan D, Tang QZ (2021) 6-gingerol protects against cardiac remodeling by inhibiting the p38 mitogen-activated protein kinase pathway. Acta Pharmacol Sin 42(10):1575–1586. https://doi.org/10.1038/s41401-020-00587-z
Article CAS PubMed PubMed Central Google Scholar
Meng D, Deng X, Wu Y, Wu J, Zhang Y, Zhang J, Zhao Y, Che Y (2023) Corilagin ameliorates macrophages inflammation in atherosclerosis through TLR4-NFκB/MAPK pathway. Heliyon 9(6):e16960. https://doi.org/10.1016/j.heliyon.2023.e16960
Article CAS PubMed PubMed Central Google Scholar
Roskoski R Jr. (2018) The role of small molecule platelet-derived growth factor receptor (PDGFR) inhibitors in the treatment of neoplastic disorders. Pharmacol Res 129:65–83. https://doi.org/10.1016/j.phrs.2018.01.021
Article CAS PubMed Google Scholar
Sahún-Español Á, Clemente C, Jiménez-Loygorri JI, Sierra-Filardi E, Herrera-Melle L, Gómez-Durán A, Sabio G, Monsalve M, Boya P, Arroyo AG (2022) P38 MAPK priming boosts VSMC proliferation and arteriogenesis by promoting PGC1α-dependent mitochondrial dynamics. Sci Rep 12(1):5938. https://doi.org/10.1038/s41598-022-09757-x
Article CAS PubMed PubMed Central Google Scholar
Shan D, Qu P, Zhong C, He L, Zhang Q, Zhong G, Hu W, Feng Y, Yang S, Yang XF, Yu J (2022) Anemoside B4 inhibits vascular smooth muscle cell proliferation, migration, and neointimal hyperplasia. Front Cardiovasc Med 9:907490. https://doi.org/10.3389/fcvm.2022.907490
Comments (0)